A controversial US-backed $1.6 million vaccine trial involving 14,000 newborns in West Africa has been cancelled

A controversial US-funded hepatitis B vaccine trial involving 14,000 newborns in Guinea-Bissau has been cancelled after the government refused to authorise the research, following international criticism over its proposed design and the risks it could pose to babies.